Richard de Bodo is co-chair of Bingham’s Intellectual Property and Life Sciences Groups. He is lead trial counsel in high stakes, cutting-edge patent and trade secret cases for many of the world’s leading corporations, including such companies as Pfizer, Broadcom, Dow Jones, Qualcomm, E*TRADE, Panasonic, Sharp, Olympus, Ricoh, Sanyo, Kyocera, HTC, Seiko Epson, Pentax, MySpace, GlaxoSmithKline, Eli Lilly, Takeda, APP Pharmaceuticals, Abraxis BioScience, Protein Design Labs, Affymetrix, Affymax, United Healthcare, and Quidel.
Rich has consistently been recognized as one of the nation’s top patent litigators and trial lawyers by Chambers USA, The Best Lawyers in America, the Legal 500, the Daily Journal, L.A. Business Journal, and Who’s Who in American Law. He has been named one of the Top IP Litigators in California by the Daily Journal, one of L.A.’s Top Lawyers by The Los Angeles Business Journal and as a Southern California Super Lawyer.
According to Chambers USA, “Clients are impressed by [Rich’s] brilliant mind and unmatched strategic skills.” Chambers quotes one of Rich’s clients as saying, “When the stakes are high, he is the only person I’d go to…[Rich] gets the job done in a measured and calm matter.” Another client stated: “Rich is the person you need when you’re faced with highly complicated IP legal matters that involve many variables.”
Rich represents clients before trial and appellate courts, arbitration panels and the International Trade Commission (ITC). He has litigated numerous cases for clients in the United States, Europe and Asia involving computer hardware and software, Internet technology, broadband communications, consumer electronics, semiconductors and other technologies.
Prior to joining Bingham, Rich served as co-chair of the Patent Litigation Group at an Am Law 100 law firm. Rich has taught trial advocacy and litigation strategy at the National Institute of Trial Advocacy, the Hastings College of Advocacy and Loyola Law School’s continuing education program. He served as a judicial clerk in the U.S. Court of Appeals for the Ninth Circuit and in the U.S. District Court.